Basis of Presentation (Tables)

9 Months Ended

Sep. 30, 2020

The dilutive and antidilutive options are shown separately in the table below.

	Three Months Ended				Nine Months Ended
	September 30				September 30
	2020		2019		2020		2019
Additional shares		758,500		592,700		545,300		617,900
Antidilutive options		646,500		1,842,200		679,000		2,030,100

ASU 2016-13

Basis Of Presentation [Line Items]

Summary of Effect of the Changes Made by the Adoption of ASU

The cumulative effect of the changes made to the Company’s Consolidated Balance Sheet on January 1, 2020 for the adoption of ASU 2016-13 was as follows:

	BALANCE AT DECEMBER 31, 2019		CHANGE DUE TO NEW STANDARD			BALANCE AT JANUARY 1, 2020
Consolidated Balance Sheets
FINANCIAL SERVICES:
ASSETS
Finance and other receivables, net	$	12,086.0	$	(6.2	)	$	12,079.8
Other assets		715.0		.1			715.1

LIABILITIES
Deferred taxes and other liabilities		790.2		(1.5	)		788.7

STOCKHOLDERS' EQUITY
Retained earnings		10,398.5		(4.6	)		10,393.9